HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Clinical Investigation

• Publication date

  2000-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI8707PMID 10811848PMCID PMC315465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

  2001cited by this paper
• Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells

  2000cited by this paper
• Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome.

  1999cited by this paper
• Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses.

  1999cited by this paper
• In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

  1999cited by this paper
• Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

  1999cited by this paper
• Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation.

  1999cited by this paper
• Control of HIV despite the discontinuation of antiretroviral therapy.

  1999cited by this paper
• Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

  1999cited by this paper
• Chemokines and cell migration in secondary lymphoid organs.

  1999cited by this paper
• Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

  1999cited by this paper
• Epizootic Hemorrhagic Disease: Analysis of Tissues by Amplification and In Situ Hybridization Reveals Widespread Orbivirus Infection at Low Copy Numbers

  1998cited by this paper
• Retrovirus-Mediated Transfer of the Herpes Simplex Type I Thymidine Kinase Gene in Alloreactive T Lymphocytes

  1998cited by this paper
• Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

  1998cited by this paper
• The Effects of Pharmacological and Lentivirus-Induced Immune Suppression on Orbivirus Pathogenesis: Assessment of Virus Burden in Blood Monocytes and Tissues by Reverse Transcription-In Situ PCR

  1998cited by this paper
• Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Hodgkin Disease. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas

  1998cited by this paper
• Use of G418 resistance to select cells retrovirally transduced with the Neo(R) gene.

  1998cited by this paper
• Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

  1998cited by this paper
• Human Herpesvirus 8 in the Prostate Glands of Men with Kaposi’s Sarcoma

  1998cited by this paper
• Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.

  1997cited by this paper
• Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood.

  1997cited by this paper
• Human herpes virus eight in prostate tissue of men with Kaposi's sarcoma

  1997cited by this paper
• Let's talk about dying

  1996cited by this paper
• Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes

  1996cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients

  1996cited by this paper
• Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

  1995cited by this paper
• Redefining cell death.

  1995cited by this paper
• Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

  1995cited by this paper
• Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

  1995cited by this paper
• Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

  1995cited by this paper
• Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.

  1995cited by this paper
• Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues.

  1995cited by this paper
• Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation.

  1995cited by this paper
• Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

  1994cited by this paper
• Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

  1994cited by this paper
• Anergy and apoptosis in CD8+ T cells from HIV-infected persons.

  1994cited by this paper
• Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals.

  1993cited by this paper
• Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry.

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• Human gene therapy comes of age

  1992cited by this paper
• Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

  1992cited by this paper
• Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

  1991cited by this paper
• Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.

  1991cited by this paper

• Immune Activation and HIV-Specific CD8+ T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers

  2016cites this paper
• Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity

  2016cites this paper
• An unexpected journey: how cancer immunotherapy has paved the way for an HIV-1 cure.

  2015cites this paper
• Chronic inflammation in HIV infection: effects on mechanisms of T cell lymph node egress, homeostasis, and turnover

  2014cites this paper
• Human AdV-specific T cells: persisting in vitro functionality despite lethal irradiation

  2014cites this paper
• Development of CD8+ T cells expressing two distinct receptors specific for MTB and HIV-1 peptides

  2013cites this paper
• Replication in Lymphoid Tissue CTL Fail to Accumulate at Sites of HIV-1

  2013cites this paper
• transduced cytotoxic T lymphocytes Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally

  2013cites this paper
• Design and Characterization of Novel Peptide-Coated Lipid Nanoparticles for Targeting Anti-HIV Drug to CD4 Expressing Cells

  2012cites this paper
• Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection

  2012cites this paper
• Enhanced Anti-HIV Efficacy of Indinavir After Inclusion in CD4-Targeted Lipid Nanoparticles

  2012cites this paper
• Estudi de l’evolució de l’envolta del VIH-1 en pacients infectats sotmesos a vacunació terapèutica amb virus autòleg inactivat

  2011cites this paper
• Gene Therapy for HIV-1 Infection

  2011cites this paper
• Stem cell-based anti-HIV gene therapy.

  2011cites this paper
• The GP120 molecule of HIV-1 and its interaction with T cells.

  2010cites this paper
• Genetic vaccination: engineering antiviral T-cell immunity through stem cells

  2010cites this paper
• Phenotypic and functional characterization of cytotoxic T lymphocytes in HIV-1 infected South African adults

  2010cites this paper
• Dynamic regulation of functionally distinct virus-specific T cells

  2010cites this paper
• Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy.

  2009cites this paper
• NanoART, neuroAIDS and CNS drug delivery.

  2009cites this paper
• Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy

  2009cites this paper
• Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice

  2009cites this paper
• Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

  2009cites this paper
• T lymphocyte engineering ex vivo for cancer and infectious disease

  2008cites this paper
• pH-dependent interactions of indinavir and lipids in nanoparticles and their ability to entrap a solute.

  2008cites this paper
• Enhancement of Human Immunodeficiency Virus (HIV)-Specific CD8+ T Cells in Cerebrospinal Fluid Compared to Those in Blood among Antiretroviral Therapy-Naïve HIV-Positive Subjects

  2008cites this paper
• T lymphocyte engineering ex vivo for cancer and infectious disease.

  2008cites this paper
• Soluble PD‐1 rescues the proliferative response of simian immunodeficiency virus‐specific CD4 and CD8 T cells during chronic infection

  2008cites this paper
• Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA

  2008cites this paper
• Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.

  2008influential citation
• Combining drug and immune therapy: a potential solution to drug resistance and challenges of HIV vaccines?

  2008cites this paper
• Redirecting Therapeutic T Cells against Myelin-Specific T Lymphocytes Using a Humanized Myelin Basic Protein-HLA-DR2-ζ Chimeric Receptor1

  2008cites this paper
• FIV Infection Induces Unique Changes in Phenotype and Cellularity in the Medial Iliac Lymph Node and Intestinal IEL

  2007cites this paper
• CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue12

  2007cites this paper
• Genetic therapies against HIV

  2007cites this paper
• Review Immune based therapies in cancer

  2007cites this paper
• Immune based therapies in cancer.

  2007cites this paper
• Decreased CXCR3+ CD8 T Cells in Advanced Human Immunodeficiency Virus Infection Suggest that a Homing Defect Contributes to Cytotoxic T-Lymphocyte Dysfunction

  2007cites this paper
• Expansion of human cytomegalovirus‐specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen‐presenting cells

  2007cites this paper
• Optimization of Lipid-Indinavir Complexes for Localization in Lymphoid Tissues of HIV-Infected Macaques

  2006cites this paper
• AIDS/HIV, Molecular and Cell Biology

  2006cites this paper
• Tetanus toxoid provides efficient T‐cell help for the induction of HA‐1H cytotoxic T cells

  2006cites this paper
• Vector-based antiviral therapy

  2006cites this paper
• Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome

  2006cites this paper
• Cellular Immunotherapy for Cytomegalovirus and HIV-1 Infection

  2006cites this paper
• Replication Differentiation with the Extent of Viral Macaques : Relationship of Effector Cell Simian Immunodeficiency Virus Infection in T Cell Dynamics during Primary + CD 8

  2005cites this paper
• Lymphocytes Th 2-Differentiated , Anti-TCR Redirected T Experimental Allergic Encephalomyelitis by IL-10-Dependent Suppression of

  2005cites this paper
• How Many Human Immunodeficiency Virus Type 1-Infected Target Cells Can a Cytotoxic T-Lymphocyte Kill?

  2005cites this paper
• Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.

  2005cites this paper
• Immunotherapy and therapeutic vaccines in HIV infection.

  2005cites this paper
• Artificial antigen-presenting cells: artificial solutions for real diseases.

  2005cites this paper
• Technological advances in adoptive immunotherapy.

  2005cites this paper
• CD8+ T Cell Dynamics during Primary Simian Immunodeficiency Virus Infection in Macaques: Relationship of Effector Cell Differentiation with the Extent of Viral Replication1

  2005cites this paper
• IL-10-Dependent Suppression of Experimental Allergic Encephalomyelitis by Th2-Differentiated, Anti-TCR Redirected T Lymphocytes1

  2005cites this paper
• Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.

  2005cites this paper
• Inmunoterapia y vacunas teraputicas en la infeccin por VIH

  2005cites this paper
• Amplification ex vivo de lymphocytes T CD8 humains spécifiques à l'aide de molécules recombinantes multimérisées.

  2005cites this paper
• Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

  2005cites this paper
• Adoptive T cell therapy: Addressing challenges in cancer immunotherapy

  2005cites this paper
• Culturing of HIV-1-specific cytotoxic T lymphocytes with interleukin-7 and interleukin-15.

  2004cites this paper
• HIV in central nervous system and behavioral development: an HIV-2287 macaque model of AIDS

  2004cites this paper
• HIV-Tat dependent chemotaxis and invasion, key aspects of Tat mediated pathogenesis

  2004cites this paper
• Quality and quantity: new strategies to improve immunotherapy of cancer.

  2004cites this paper
• Darwinism and pharmacogenomics : from ‘ one treatment fits all ’ to ‘ selection of the richest ’ ?

  2004cites this paper
• Resistance of HIV-infected cells to cytotoxic T lymphocytes.

  2004cites this paper
• Targeting T cell responses by selective chemokine receptor expression.

  2003cites this paper
• Anatomical loci of HIV-associated immune activation and association with viraemia.

  2003cites this paper
• Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system

  2003cites this paper
• How HIV evades CTL recognition.

  2003cites this paper
• Natural history and pathogenesis of human immunodeficiency virus infection.

  2003cites this paper
• An artificial solution for adoptive immunotherapy.

  2003cites this paper
• Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.

  2003cites this paper
• Natural History and Pathogenesis of Human Immunodeficiency Virus Infection

  2003cites this paper
• Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes

  2003cites this paper
• Identification of a murine CD 28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function

  2003cites this paper
• Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function.

  2003cites this paper
• Adoptive T cell therapy--immune monitoring and MHC multimers.

  2003cites this paper
• Lipid–Drug Association Enhanced HIV-1 Protease Inhibitor Indinavir Localization in Lymphoid Tissues and Viral Load Reduction: A Proof of Concept Study in HIV-2287-Infected Macaques

  2003cites this paper
• Immunologic control of HIV-1.

  2002cites this paper
• Genetically engineered T-cells for adoptive immunotherapy.

  2002cites this paper
• Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus.

  2002cites this paper
• Adoptive transfer of simian immunodeficiency virus (SIV) naïve autologous CD4(+) cells to macaques chronically infected with SIV is sufficient to induce long-term nonprogressor status.

  2002cites this paper
• Immune Intervention in AIDS

  2002cites this paper
• Biodistribution and Retention Time of Retrovirally Labeled T Lymphocytes in Mice is Strongly Influenced by the Culture Period Before Infusion

  2002cites this paper
• Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy

  2002influential citation
• Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection

  2002cites this paper
• Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells

  2002cites this paper
• Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection.

  2002cites this paper
• Immunopathogenesis of human immunodeficiency virus: implications for immune-based therapies.

  2001cites this paper
• T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: impact of highly active antiretroviral therapy.

  2001cites this paper
• Human immunodeficiency virus pathogenesis: insights from studies of lymphoid cells and tissues.

  2001cites this paper
• In vivo tracking of tumor-specific T cells.

  2001cites this paper
• Transduction of an IL-2 Gene into Human Melanoma-Reactive Lymphocytes Results in Their Continued Growth in the Absence of Exogenous IL-2 and Maintenance of Specific Antitumor Activity

  2001cites this paper
• Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells.

  2001cites this paper
• Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate Model

  2001cites this paper
• Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity.

  2001cites this paper
• Human Immunodeficiency Virus Pathogenesis: Insights from Studies of Lymphoid Cells and Tissues

  2001cites this paper
• Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.

  2001cites this paper
• Proving HIV-1 immunity: new tools offer new opportunities.

  2000cites this paper
• Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis.

  2000cites this paper